Short Interest in Aytu BioPharma, Inc. Decreases By 14.4
| AYTU Stock | USD 1.62 0.02 1.25% |
Slightly above 64% of all Aytu BioScience's private investors are looking to take a long position. The analysis of overall sentiment of trading Aytu BioScience stock suggests that some investors are interested at this time. Aytu BioScience's investing sentiment can be driven by a variety of factors including economic data, Aytu BioScience's earnings reports, geopolitical events, and overall market trends.
Aytu |
Aytu BioPharma, Inc. was the recipient of a significant decline in short interest during the month of October. As of October 31st, there was short interest totalling 192,800 shares, a decline of 14.4 percent from the October 15th total of 225,200 shares. Based on an average trading volume of 24,700 shares,
Read at thelincolnianonline.com
 |
Aytu BioScience Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Aytu BioScience can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Aytu BioScience Fundamental Analysis
We analyze Aytu BioScience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aytu BioScience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aytu BioScience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Liabilities
Current Liabilities Comparative Analysis
Aytu BioScience is currently under evaluation in current liabilities category among its peers. Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Aytu BioScience Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aytu BioScience stock to make a market-neutral strategy. Peer analysis of Aytu BioScience could also be used in its relative valuation, which is a method of valuing Aytu BioScience by comparing valuation metrics with similar companies.
Peers
Aytu BioScience Related Equities
| AQST | Aquestive Therapeutics | 5.74 | ||||
| SXTC | China SXT | 5.13 | ||||
| IRWD | Ironwood Pharmaceuticals | 4.26 | ||||
| FLGC | Flora Growth | 1.29 | ||||
| LFCR | Lifecore Biomedical | 0.81 | ||||
| PTPI | Petros Pharmaceuticals | 0.37 | ||||
| SGIOY | Shionogi | 0.29 | ||||
| AVDL | Avadel Pharmaceuticals | 0.18 | ||||
| EVOK | Evoke Pharma | 0.46 | ||||
| ESPR | Esperion Therapeutics | 1.17 | ||||
| SHPH | Shuttle Pharmaceuticals | 2.30 | ||||
| DERM | Journey Medical | 3.31 | ||||
| SNOA | Sonoma Pharmaceuticals | 4.45 | ||||
| SBFM | Sunshine Biopharma | 10.20 |
Additional Tools for Aytu Stock Analysis
When running Aytu BioScience's price analysis, check to measure Aytu BioScience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aytu BioScience is operating at the current time. Most of Aytu BioScience's value examination focuses on studying past and present price action to predict the probability of Aytu BioScience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aytu BioScience's price. Additionally, you may evaluate how the addition of Aytu BioScience to your portfolios can decrease your overall portfolio volatility.